Negative regulation of the FOXO3a transcription factor by mTORC2 induces a pro-survival response following exposure to ultraviolet-B irradiation

被引:25
作者
Feehan, Robert P. [1 ]
Shantz, Lisa M. [1 ]
机构
[1] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Room C4731,500 Univ Dr, Hershey, PA 17033 USA
关键词
Keratinocyte; UVB; Apoptosis; FOXO; Mammalian target of rapamycin (mTOR); Cancer chemoprevention; NONMELANOMA SKIN-CANCER; SQUAMOUS-CELL CARCINOMA; UVB-INDUCED APOPTOSIS; MAMMALIAN TARGET; GENE-EXPRESSION; DNA-BINDING; PROMOTES TUMORIGENESIS; COMPLEX INTEGRITY; 14-3-3; PROTEINS; AKT;
D O I
10.1016/j.cellsig.2016.03.013
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Exposure to ultraviolet-B (UVB) irradiation, the principal cause of non-melanoma skin cancer (NMSC), activates both the rapamycin-sensitive mammalian target of rapamycin complex 1 (mTORC1) and the rapamycin-resistant mTORC2. We have previously reported that UVB-induced keratinocyte survival is dependent on mTORC2, though the specific mechanism is not well understood. FOXO3a is an important transcription factor involved in regulating cell survival. The activity of FOXO3a is reduced as a result of protein kinase B (AKT/PKB) activation, which is downstream of mTORC2; however, the specific function of FOXO3a during UVB-induced apoptosis is unclear. In this study, we establish that in cells with wild-type mTORC2 activity, FOXO3a is quickly phosphorylated in response to UVB and sequestered in the cytoplasm. In contrast, loss of mTORC2 causes FOXO3a to be localized to the nucleus and sensitizes cells to UVB-induced apoptosis. Furthermore, this sensitization is rescued by knockdown of FOXO3a. Taken together, these studies provide strong evidence that inhibition of mTORC2 enhances UVB-induced apoptosis in a FOXO3a-dependent manner, and suggest that FOXO3a activation by mTORC2 inhibitors may be a valuable chemopreventive target in NMSC. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:798 / 809
页数:12
相关论文
共 81 条
[1]   mTOR signaling for biological control and cancer [J].
Alayev, Anya ;
Holz, Marina K. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2013, 228 (08) :1658-1664
[2]   MTOR signalling in human cancer [J].
Albanell, J. ;
Dalmases, A. ;
Rovira, A. ;
Rojo, F. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2007, 9 (08) :484-493
[3]   Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha [J].
Alessi, DR ;
James, SR ;
Downes, CP ;
Holmes, AB ;
Gaffney, PRJ ;
Reese, CB ;
Cohen, P .
CURRENT BIOLOGY, 1997, 7 (04) :261-269
[4]   Dual Inactivation of Akt and ERK by TIC10 Signals Foxo3a Nuclear Translocation, TRAIL Gene Induction, and Potent Antitumor Effects [J].
Allen, Joshua E. ;
Krigsfeld, Gabriel ;
Mayes, Patrick A. ;
Patel, Luv ;
Dicker, David T. ;
Patel, Akshal S. ;
Dolloff, Nathan G. ;
Messaris, Evangelos ;
Scata, Kimberly A. ;
Wang, Wenge ;
Zhou, Jun-Ying ;
Wu, Gen Sheng ;
El-Deiry, Wafik S. .
SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (171)
[5]   Myc and PI3K/AKT signaling cooperatively repress FOXO3a-dependent PUMA and GADD45a gene expression [J].
Amente, Stefano ;
Zhang, Jiyuan ;
Lavadera, Miriam Lubrano ;
Lania, Luigi ;
Avvedimento, Enrico Vittorio ;
Majello, Barbara .
NUCLEIC ACIDS RESEARCH, 2011, 39 (22) :9498-9507
[6]   MOLECULAR MECHANISMS OF ULTRAVIOLET-RADIATION CARCINOGENESIS [J].
ANANTHASWAMY, HN ;
PIERCEALL, WE .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1990, 52 (06) :1119-1136
[7]  
[Anonymous], 2013, Cancer Facts and Figures 2013
[8]   MST1 is a key regulator of beta cell apoptosis and dysfunction in diabetes [J].
Ardestani, Amin ;
Paroni, Federico ;
Azizi, Zahra ;
Kaur, Supreet ;
Khobragade, Vrushali ;
Yuan, Ting ;
Frogne, Thomas ;
Tao, Wufan ;
Oberholzer, Jose ;
Pattou, Francois ;
Conte, Julie Kerr ;
Maedler, Kathrin .
NATURE MEDICINE, 2014, 20 (04) :385-+
[9]   MAMMALIAN TARGET OF RAPAMYCIN IN INFLAMMATORY SKIN CONDITIONS [J].
Balato, A. ;
Di Caprio, R. ;
Lembo, S. ;
Mattii, M. ;
Megna, M. ;
Schiattarella, M. ;
Tarantino, G. ;
Balato, N. ;
Ayala, F. ;
Monfrecola, G. .
EUROPEAN JOURNAL OF INFLAMMATION, 2014, 12 (02) :341-350
[10]   Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management [J].
Berg, D ;
Otley, CC .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 47 (01) :1-17